Trademark: 88425742
Word
BC
Status
Registered
Status Code
700
Status Date
Tuesday, July 20, 2021
Serial Number
88425742
Registration Number
6422741
Registration Date
Tuesday, July 20, 2021
Mark Type
5000
Filing Date
Friday, May 10, 2019
Published for Opposition
Tuesday, May 4, 2021

Trademark Owner History
Aphria Inc. - Original Registrant

Classifications
3 Bath additives, namely, cosmetic bath salts, bath melts, bath herbs, bubble bath, foam bath, bath bombs, bath gel, bath beads, bath flakes, bath crystals; non-medicated lip care preparations, non-medicated lip conditioners, liquid soaps, namely, non-medicated bath soaps, non-medicated liquid soaps, liquid soaps for laundry; non-medicated skin care preparations; bath oils; bath oils for cosmetic purposes; beauty care cosmetics; beauty creams for body care; beauty gels; beauty lotions; body and beauty care cosmetics; body creams; cosmetic body oils; cosmetic creams; cosmetic oils; cosmetics and make-up; face and body lotions; face and body milk; face lotion; hair care preparations; hair styling preparations; hand cream; hand lotions; lip glosses; massage creams; massage oils; non-medicated bubble bath preparations; non-medicated preparations for the care of hair; non-medicated preparations for the care of skin; non-medicated preparations for the care of the scalp; oils for toiletry purposes; skin creams; skin emollients; skin lotions; skin soap; non-medicated soaps for body care; non-medicated soaps for personal use, namely, cream soaps, bath soaps, bar soaps, paper soaps; all of the foregoing with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
5 Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
29 Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely, butter; fruit based energy food bars; seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
30 Food products containing hemp and derivatives thereof, namely, chocolates, cookies, brownies, candy and granola-based, cereal based food energy bars; tea, namely, teas containing hemp and derivatives thereof; all of the foregoing with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
31 Live hemp plants; hemp seeds for planting and agricultural use; all of the foregoing with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis
32 Smoothies, fruit beverages and fruit juices, carbonated soft drinks, and energy drinks each containing hemp and derivatives thereof; all of the foregoing with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
34 Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils, not including essential oils, in the nature of liquids for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives, not including essential oils, for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD or exclusively for use with goods having a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD; smokers' articles, namely, pouches for use with hemp, lighters for smokers
Color is not claimed as a feature of the mark.
The mark consists of the stylized letters "BC".

Trademark Events
Oct 25, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 25, 2021
Teas Change Of Correspondence Received
Oct 25, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 25, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 25, 2021
Teas Change Of Owner Address Received
Jul 20, 2021
Registered-Principal Register
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Mar 31, 2021
Approved For Pub - Principal Register
Mar 29, 2021
Examiner's Amendment Entered
Mar 29, 2021
Notification Of Examiners Amendment E-Mailed
Mar 29, 2021
Examiners Amendment E-Mailed
Mar 29, 2021
Examiners Amendment -Written
Mar 13, 2021
Teas/Email Correspondence Entered
Mar 13, 2021
Correspondence Received In Law Office
Mar 13, 2021
Assigned To Lie
Dec 10, 2020
Teas Response To Office Action Received
Jun 10, 2020
Notification Of Non-Final Action E-Mailed
Jun 10, 2020
Non-Final Action E-Mailed
Jun 10, 2020
Non-Final Action Written
Apr 20, 2020
Teas/Email Correspondence Entered
Apr 19, 2020
Correspondence Received In Law Office
Apr 19, 2020
Teas Response To Office Action Received
Oct 18, 2019
Notification Of Non-Final Action E-Mailed
Oct 18, 2019
Non-Final Action E-Mailed
Oct 18, 2019
Non-Final Action Written
Oct 15, 2019
Assigned To Examiner
May 30, 2019
Assigned To Examiner
May 28, 2019
New Application Office Supplied Data Entered In Tram
May 14, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24